These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21832236)

  • 21. Editorial Comment on type 1 diabetes and antigen-specific immunotherapy.
    Lernmark Å; Larsson HE
    J Intern Med; 2011 Aug; 270(2):132-5. PubMed ID: 21668820
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus.
    Eisenbarth GS; Srikanta S; Jackson R; Rabinowe S; Dolinar R; Aoki T; Morris MA
    Diabetes Res; 1985 Nov; 2(6):271-6. PubMed ID: 3878262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outlook for immune intervention in type I diabetes.
    Grob PJ
    Curr Probl Clin Biochem; 1983; 12():119-40. PubMed ID: 6360542
    [No Abstract]   [Full Text] [Related]  

  • 24. Disease-modifying immunotherapy for the management of autoimmune diabetes.
    Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
    Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunointervention in type 1 diabetes mellitus].
    Vialettes B
    Diabete Metab; 1992; 18(1):3-10; discussion 11-3. PubMed ID: 1563533
    [No Abstract]   [Full Text] [Related]  

  • 26. The treatment of diabetes mellitus in childhood.
    Malins JM
    Practitioner; 1970 Jan; 204(219):157-62. PubMed ID: 5411151
    [No Abstract]   [Full Text] [Related]  

  • 27. Paths to a cure. Research are going down many roads in their quest to cure diabetes.
    Mettner J
    Minn Med; 2011 Aug; 94(8):24-8. PubMed ID: 21957812
    [No Abstract]   [Full Text] [Related]  

  • 28. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?
    Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ
    Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes resources. Getting involved in clinical trials.
    Dairman T
    Diabetes Self Manag; 2004; 21(6):87-9. PubMed ID: 15688471
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunotherapy for type 1 diabetes.
    Frumento D; Ben Nasr M; El Essawy B; D'Addio F; Zuccotti GV; Fiorina P
    J Endocrinol Invest; 2017 Aug; 40(8):803-814. PubMed ID: 28260183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus].
    Karachunskiĭ MA; Gergert VIa; Iakovleva OB
    Probl Tuberk; 1997; (6):59-60. PubMed ID: 9503939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging treatments for the prevention of type 1 diabetes.
    Raskin P; Mohan A
    Expert Opin Emerg Drugs; 2010 Jun; 15(2):225-36. PubMed ID: 20384544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of diabetes mellitus in older patients: pill or pen?].
    Erkelens DW
    Ned Tijdschr Geneeskd; 1989 Jun; 133(22):1107-9. PubMed ID: 2662030
    [No Abstract]   [Full Text] [Related]  

  • 34. [Type 1 diabetes: the rediscovery of insulin].
    Boitard C
    Journ Annu Diabetol Hotel Dieu; 2007; ():181-9. PubMed ID: 18610769
    [No Abstract]   [Full Text] [Related]  

  • 35. Future trends in diabetes management.
    George CM
    Nephrol Nurs J; 2009; 36(5):477-83. PubMed ID: 19856809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune intervention with anti-CD3 in diabetes.
    Harlan DM; von Herrath M
    Nat Med; 2005 Jul; 11(7):716-8. PubMed ID: 16015359
    [No Abstract]   [Full Text] [Related]  

  • 37. Diabetes cure--is the glass half full?
    Bromberg JS; LeRoith D
    N Engl J Med; 2006 Sep; 355(13):1372-4. PubMed ID: 17005956
    [No Abstract]   [Full Text] [Related]  

  • 38. [Does the current knowledge on the pathogenesis of type 1 diabetes justify immunotherapeutic intervention?].
    Pozzilli P; Signore A; Andreani D
    Recenti Prog Med; 1986 May; 77(5):245-8. PubMed ID: 3526461
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diabetes mellitus and platelet half-life].
    Banfi L; Vecchi C; Galetti A; Giussani R; Guzzini F
    Clin Ter; 1987 May; 121(4):305-10. PubMed ID: 2973867
    [No Abstract]   [Full Text] [Related]  

  • 40. Type I diabetes mellitus: lessons for human autoimmunity.
    Pugliese A; Eisenbarth GS
    J Lab Clin Med; 1992 Sep; 120(3):363-6. PubMed ID: 1517681
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.